2013
DOI: 10.1016/j.canlet.2012.11.044
|View full text |Cite
|
Sign up to set email alerts
|

In vivo molecular imaging of epidermal growth factor receptor in patients with colorectal neoplasia using confocal laser endomicroscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
40
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 53 publications
(41 citation statements)
references
References 33 publications
1
40
0
Order By: Relevance
“…An anti-EGFR antibody has been developed that binds to colonic neoplasia, but no targeting antibodies have been developed for BE neoplasia. 32 A small fluorescent-labeled peptide specific for neoplastic BE has also been developed and tested in EMR specimens. 33 The fluorescence intensity was measured for each specimen and was found to be highest in neoplastic BE tissue and lowest in squamous and gastric mucosa.…”
Section: Future Developments In Clementioning
confidence: 99%
“…An anti-EGFR antibody has been developed that binds to colonic neoplasia, but no targeting antibodies have been developed for BE neoplasia. 32 A small fluorescent-labeled peptide specific for neoplastic BE has also been developed and tested in EMR specimens. 33 The fluorescence intensity was measured for each specimen and was found to be highest in neoplastic BE tissue and lowest in squamous and gastric mucosa.…”
Section: Future Developments In Clementioning
confidence: 99%
“…An EGFR-specific fluorescence signal was present in 18/19 CRC patients and 12/18 patients with intestinal adenomas, whereas only weak signals were found in normal mucosa. Importantly, no antibody formation against the labeled probe was found, although this was tested in only four patients [27]. A major breakthrough was the recent first-in-human pilot study where a cyclic peptide conjugated to a fluorescent cyanine dye that binds the human tyrosine kinase hepatocyte growth factor receptor (c-Met) was i.v.…”
Section: Endoscopic Molecular Imaging Studies In the Gastrointestinalmentioning
confidence: 98%
“…[1][2][3][4] Through the use of vascular and molecular contrast agents, multiple structural and functional events can be directly observed, including angiogenesis and monoclonal antibody-antigen binding to epithelial targets. 5 In aggregate, these technologies have opened new fields of endomicroscopy and functional imaging of the GI tract at cellular and subcellular level.…”
mentioning
confidence: 99%
“…10 Molecular imaging with tagged monoclonal antibody has enabled imaging of antiendothelial growth factor receptor monoclonal antibody binding to targets and predication of response to endothelial growth factor receptor chemotherapy. 5,9,11 Imaging of overt and microscopic inflammation is now well established. Kiesslich et al 9,11 demonstrated epithelial cell shedding in the small bowel of patients with inflammatory bowel disease and further demonstrated that residual inflammation was predictive of relapse.…”
mentioning
confidence: 99%
See 1 more Smart Citation